Literature DB >> 8372918

Classification of Menière's disease.

J J Shea1.   

Abstract

To create a rational treatment system for Meniere's disease, it is helpful to divide Meniere's disease into five stages according to the signs, symptoms, pathology, and natural history by recalling what is known for certain and what is probably true about Meniere's disease. It is known that Meniere's disease is attributable to endolymphatic hydrops, caused by a small, malfunctioning endolymphatic sac, abnormally placed since birth, and Meniere's disease is therefore a congenital disorder of the endolymphatic sac. It is probably true that there is often an immune, viral, metabolic, or other insult to the inner ear, that disturbs the balance between the cochlea, where endolymph is produced, and the endolymphatic sac, where most of it is absorbed. Using this five-stage classification, it is possible to separate Meniere's disease into the first three stages, for which different but reasonable treatments are possible, and the last two stages, for which no treatments are effective.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8372918

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  7 in total

Review 1.  Intratympanic steroid therapy for inner ear diseases, a review of the literature.

Authors:  M J R C Alles; M A der Gaag; R J Stokroos
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-25       Impact factor: 2.503

2.  Video head impulse test and caloric test in definite Ménière's disease.

Authors:  Siriporn Limviriyakul; Chadarthan Luangsawang; Kanokrat Suvansit; Sarun Prakairungthong; Kanthong Thongyai; Suvajana Atipas
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-11-20       Impact factor: 2.503

3.  Disability perception in Menière's disease: when, how much and why?

Authors:  Andres Soto-Varela; Belen Huertas-Pardo; Pilar Gayoso-Diz; Sofia Santos-Perez; Ines Sanchez-Sellero
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-01       Impact factor: 2.503

Review 4.  Pharmacological treatment of vertigo.

Authors:  Timothy C Hain; Mohammed Uddin
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

5.  Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial.

Authors:  Paul R Lambert; John Carey; Anthony A Mikulec; Carl LeBel
Journal:  Otol Neurotol       Date:  2016-12       Impact factor: 2.311

6.  Towards a new staging of Ménière's disease: a vestibular approach.

Authors:  O A Sobhy; D M Elmoazen; F A Abd-Elbaky
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-12       Impact factor: 2.124

Review 7.  Usefulness of Video Head Impulse Test Results in the Identification of Meniere's Disease.

Authors:  Brahim Kaci; Mujda Nooristani; Tamara Mijovic; Maxime Maheu
Journal:  Front Neurol       Date:  2020-10-29       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.